National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Application for Inclusion in NCI Cancer Genetics Services Directory (PDQ®)



Criteria for Inclusion






Application



Page Options
View Entire Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
The Cancer Genome Atlas Reports Brain Tumors Study

New Study of Targeted Therapies for Breast Cancer

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Criteria for Inclusion

NCI CANCER GENETICS SERVICES DIRECTORY
CRITERIA FOR INCLUSION



1.

Licensed, board certified, or board eligible in their profession.

2.

A member of one of the following professional organizations or special interest groups:
  • American College of Medical Genetics (ACMG)
  • American Psychological Association
  • American Society of Clinical Oncology (ASCO)
  • American Society of Human Genetics (ASHG)
  • International Society of Nurses in Genetics (ISONG)
  • National Society of Genetic Counselors (NSGC)
  • NSGC Special Interest Group in Cancer
  • Oncology Nursing Society (ONS)
  • ONS Cancer Genetics Special Interest Group
3. Specific training or professional experience in cancer genetics. This could include:
  • Publications authored
  • Courses taken
  • Years of experience
  • Number of patients counseled per year about genetic susceptibility to cancer
  • Investigator or research professional on genetics clinical trials
  • Clinical preceptorships taken
4. A member of or affiliated with an interdisciplinary team with substantial expertise in cancer genetics. Members of the team should be able to provide the following expertise in relation to cancer genetics:
  • Patient genetics education
  • Patient cancer-risk assessment
  • Appropriate pre- and post-test counseling and informed consent (including ethical, legal, and social issues related to testing and disclosure of test results)
  • Genetic susceptibility testing (including information on limitations, specific tests available, and regulations concerning testing procedures such as CLIA and CAP/ACMG)
  • Follow-up plan of care (including medical care, psychological support, and counseling about options for prevention or early detection guidelines)
5. Willing to accept referrals.

Back to Top

Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov